SCHEMBL23301660

SCHEMBL23301660

O=C(O)CCCCCCCCN1CCN(c2ccc3c(c2)C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 17/20 0.65
DDB1 Q16531 10/20 0.49
PTK2 Q05397 1/20 0.48
ALDH1A1 P00352 1/20 0.47
CHRM2 P08172 1/20 0.47
OPRM1 P35372 1/20 0.47
IKZF3 Q9UKT9 1/20 0.47
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HPGDS O60760 2/20 0.47
BRD9 Q9H8M2 1/20 0.47
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
IRAK1 P51617 1/20 0.47
NTRK3 Q16288 1/20 0.47
HASPIN Q8TF76 1/20 0.47
CDK19 Q9BWU1 1/20 0.47
IRAK4 Q9NWZ3 1/20 0.47
IRAK3 Q9Y616 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24735578 1.00 CRBN (0.65) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL27176465 1.00 CRBN (0.65) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL23300971 1.00 CRBN (0.65) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL30228775 1.00 CRBN (0.65) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL27176464 1.00 CRBN (0.65) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL24206811 0.99 CRBN (0.66) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL29841537 0.99 CRBN (0.66) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL21855314 0.96 CRBN (0.67) CRBNDDB1PTK2ALDH1A1CHRM2
SCHEMBL29617045 0.93 CRBN (0.70) CRBNDDB1ALDH1A1CHRM2OPRM1
SCHEMBL23705499 0.93 CRBN (0.70) CRBNDDB1ALDH1A1CHRM2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051674-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-09-07 EP disclosed
WO-2021083949-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2021-05-06 WO disclosed